{"id":69347,"date":"2021-12-09T09:45:30","date_gmt":"2021-12-09T08:45:30","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/"},"modified":"2025-10-13T15:31:28","modified_gmt":"2025-10-13T13:31:28","slug":"ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/","title":{"rendered":"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n"},"content":{"rendered":"<p><strong><a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/ona-therapeutics\/\" target=\"_blank\" rel=\"noopener\">ONA Therapeutics<\/a>, con sede en el Parque Cient\u00edfico de Barcelona y centrada en el descubrimiento y desarrollo de biol\u00f3gicos terap\u00e9uticos dirigidos al metabolismo de los l\u00edpidos para el c\u00e1ncer avanzado, ha nombrado al Dr. Michel Detheux presidente independiente de su consejo de administraci\u00f3n.<\/strong><\/p>\n<p>El <strong>Dr. Michel\u00a0Detheux\u00a0<\/strong>es un veterano ejecutivo de biotecnolog\u00eda con 25 a\u00f1os de experiencia en la industria. Actualmente, es el presidente y director ejecutivo de\u00a0iTeos\u00a0Therapeutics\u00a0(NASDAQ:\u00a0ITOS), una empresa de biotecnolog\u00eda en etapa cl\u00ednica que cotiza en bolsa y que desarrolla nuevas terapias\u00a0inmuno-oncol\u00f3gicas\u00a0centradas en los mecanismos clave de la inmunosupresi\u00f3n. Ha encabezado varios aumentos de capital y transacciones para\u00a0iTeos, incluida una oferta p\u00fablica inicial en Nasdaq y colaboraciones estrat\u00e9gicas con\u00a0Pfizer\u00a0y\u00a0GlaxoSmithKline.<\/p>\n<p>El <strong>Dr. Detheux e<\/strong>studi\u00f3 en la Universit\u00e9 Catholique de Louvain, recibi\u00f3 su licenciatura y su doctorado en bioqu\u00edmica, antes de completar su posdoctorado en la Universidad de Glasgow. Detheux tambi\u00e9n tiene un certificado empresarial de Solvay Business School.<\/p>\n<p>Seg\u00fan <strong>Valerie Vanhooren,<\/strong> directora ejecutiva y cofundadora de ONA Therapeutics: \u00a8Estamos encantados de dar la bienvenida al Dr. Michel Detheux como presidente independiente del Consejo de Administraci\u00f3n. La experiencia y el historial excelente del Dr. Detheux ser\u00e1n invaluables para ONA a medida que avanzamos en nuestra l\u00ednea precl\u00ednica de terapias nuevas que abordan la necesidad m\u00e9dica insatisfecha de los pacientes con c\u00e1ncer avanzado\u00bb.<\/p>\n<p>El <strong>Dr. Michel Detheux,<\/strong> presidente de ONA Therapeutics, afirma: \u00abEstoy encantado de unirme a ONA Therapeutics en esta etapa del crecimiento y la progresi\u00f3n de la empresa. ONA tiene una combinaci\u00f3n \u00fanica de ciencia nueva, una buena base de inversores y talentos brillantes para desarrollar terapias altamente innovadoras\u00bb.<\/p>\n<p><strong>\u00bb M\u00e1s informaci\u00f3n: <a href=\"https:\/\/ona-therapeutics.com\/ona-therapeutics-appoints-dr-michel-detheux-as-independent-chair-to-board-of-directors\/\" target=\"_blank\" rel=\"noopener\">web de ONA Therapeutics [+]<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ONA Therapeutics, con sede en el Parque Cient\u00edfico de Barcelona y centrada en el descubrimiento y desarrollo de biol\u00f3gicos terap\u00e9uticos dirigidos al metabolismo de los l\u00edpidos para el c\u00e1ncer avanzado,&#8230;<\/p>\n","protected":false},"author":4,"featured_media":69146,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-69347","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"ONA Therapeutics, con sede en el Parque Cient\u00edfico de Barcelona y centrada en el descubrimiento y desarrollo de biol\u00f3gicos terap\u00e9uticos dirigidos al metabolismo de los l\u00edpidos para el c\u00e1ncer avanzado,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-09T08:45:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:31:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/12\/MichelDetheux_web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Azucena Berea\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Azucena Berea\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/\"},\"author\":{\"name\":\"Azucena Berea\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\"},\"headline\":\"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n\",\"datePublished\":\"2021-12-09T08:45:30+00:00\",\"dateModified\":\"2025-10-13T13:31:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/\"},\"wordCount\":316,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/MichelDetheux_web.jpg\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/\",\"name\":\"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/MichelDetheux_web.jpg\",\"datePublished\":\"2021-12-09T08:45:30+00:00\",\"dateModified\":\"2025-10-13T13:31:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/MichelDetheux_web.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/MichelDetheux_web.jpg\",\"width\":900,\"height\":320},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\",\"name\":\"Azucena Berea\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"caption\":\"Azucena Berea\"},\"sameAs\":[\"https:\\\/\\\/www.pcb.ub.edu\"],\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/aberea\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/","og_locale":"es_ES","og_type":"article","og_title":"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n - Parc Cient\u00edfic de Barcelona","og_description":"ONA Therapeutics, con sede en el Parque Cient\u00edfico de Barcelona y centrada en el descubrimiento y desarrollo de biol\u00f3gicos terap\u00e9uticos dirigidos al metabolismo de los l\u00edpidos para el c\u00e1ncer avanzado,...","og_url":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2021-12-09T08:45:30+00:00","article_modified_time":"2025-10-13T13:31:28+00:00","og_image":[{"width":900,"height":320,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/12\/MichelDetheux_web.jpg","type":"image\/jpeg"}],"author":"Azucena Berea","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Azucena Berea","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/"},"author":{"name":"Azucena Berea","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239"},"headline":"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n","datePublished":"2021-12-09T08:45:30+00:00","dateModified":"2025-10-13T13:31:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/"},"wordCount":316,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/12\/MichelDetheux_web.jpg","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/","url":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/","name":"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/12\/MichelDetheux_web.jpg","datePublished":"2021-12-09T08:45:30+00:00","dateModified":"2025-10-13T13:31:28+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/12\/MichelDetheux_web.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/12\/MichelDetheux_web.jpg","width":900,"height":320},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/ola-therapeutics-nombra-michel-detheux-como-presidente-independiente-del-consejo-de-administracion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"ONA Therapeutics nombra a Michel Detheux presidente independiente del consejo de administraci\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239","name":"Azucena Berea","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","caption":"Azucena Berea"},"sameAs":["https:\/\/www.pcb.ub.edu"],"url":"https:\/\/www.pcb.ub.edu\/es\/author\/aberea\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/69347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=69347"}],"version-history":[{"count":2,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/69347\/revisions"}],"predecessor-version":[{"id":69349,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/69347\/revisions\/69349"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/69146"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=69347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=69347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=69347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}